Search
for
Sort by
Research 61–90 of 702
- The Role of Janus Kinase Inhibitors in Dermatology
- The use of phosphodiesterase inhibitors for the treatment of alopecia
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- General Dermatology
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- The role of lymphocytes in the development and treatment of alopecia areata
- The role of janus kinases in the treatment of autoimmune skin diseases
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Epidermal Notch1 recruits innate lymphoid cells to orchestrate normal skin repair
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Abstracts
- Nuevas poblaciones con riesgo cardiovascular aumentado: enfermedad cardiovascular en las enfermedades dermatológicas
- Novel therapies for alopecia areata: The era of rational drug development
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Hidradenitis Suppurativa
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Psoriasis del cuero cabelludo etiología, diagnóstico y tratamiento
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Pharmacotherapy of alopecia areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream